Cyano Biotech (Germany)
Cyano Biotech identifies and characterises natural products by screening cyanobacteria and optimises bioactive compounds regarding harmacological needs employing combinatorial biosynthesis generating novel lead compounds for the pharma industry.
Basic Information
- Category: business
- Website: http://www.cyano-biotech.com/content/home/index.php
Documented Facts
- Inception (Wikidata): 2004 (Source 2: Wikidata Q107519528, revision 2474180171)
- Country (Wikidata; date unspecified): Germany (Source 2: Wikidata Q107519528, revision 2474180171; Source 3: Wikidata label: Q183, revision 2557182420)
Evidence and Sources
- Cyano Biotech (Germany) — Official Site (official)
- Wikidata Q107519528, revision 2474180171 (knowledge-base)
- Wikidata label: Q183, revision 2557182420 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Cyano Biotech (Germany).
- Canonical profile: https://brandsource.ai/brands/cyano-biotech-germany
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/cyano-biotech-germany/json-ld
- Citation profile API: https://brandsource.ai/api/brands/cyano-biotech-germany/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Partial
- Profile completeness: Source-backed profile (83/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Cyano Biotech identifies and characterises natural products by screening cyanobacteria and optimises bioactive compounds regarding harmacological needs employing combinatorial biosynthesis generating novel lead compounds for the pharma industry.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 2 structured facts available for extraction.
Known data gaps
- Profile enrichment is incomplete
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.